JGP Global Gestao de Recursos’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $240K | Buy |
537
+5
| +0.9% | +$2.33K | 1.04% | 18 |
|
|
2025
Q4 | $241K | Sell |
532
-54
| -9% | -$23.3K | 0.14% | 36 |
|
|
2025
Q3 | $230K | Buy |
586
+5
| +0.9% | +$2.09K | 0.13% | 29 |
|
|
2025
Q2 | $259K | Sell |
581
-2
| -0.3% | -$922 | 0.13% | 37 |
|
|
2025
Q1 | $283K | Sell |
583
-385
| -40% | -$179K | 0.22% | 26 |
|
|
2024
Q4 | $390K | Sell |
968
-1
| -0.1% | -$464 | 0.89% | 23 |
|
|
2024
Q3 | $451K | Sell |
969
-77
| -7% | -$37K | 0.88% | 19 |
|
|
2024
Q2 | $490K | Sell |
1,046
-12
| -1% | -$5.21K | 0.62% | 16 |
|
|
2024
Q1 | $442K | Sell |
1,058
-434
| -29% | -$183K | 0.28% | 27 |
|
|
2023
Q4 | $607K | Sell |
1,492
-5
| -0.3% | -$1.85K | 0.36% | 21 |
|
|
2023
Q3 | $521K | Sell |
1,497
-16
| -1% | -$5.6K | 0.33% | 25 |
|
|
2023
Q2 | $532K | Sell |
1,513
-1,683
| -53% | -$567K | 0.37% | 34 |
|
|
2023
Q1 | $1.51M | Buy |
3,196
+1,441
| +82% | +$432K | 1.57% | 11 |
|
|
2022
Q4 | $507K | Sell |
1,755
-4
| -0.2% | -$1.22K | 0.36% | 28 |
|
|
2022
Q3 | $509K | Buy |
1,759
+74
| +4% | +$21.3K | 0.43% | 21 |
|
|
2022
Q2 | $475K | Sell |
1,685
-11
| -0.6% | -$2.94K | 0.36% | 26 |
|
|
2022
Q1 | $443K | Sell |
1,696
-892
| -34% | -$212K | 0.25% | 34 |
|
|
2021
Q4 | $568K | Sell |
2,588
-4
| -0.2% | -$778 | 0.26% | 26 |
|
|
2021
Q3 | $470K | Buy |
2,592
+283
| +12% | +$55.3K | 0.17% | 39 |
|
|
2021
Q2 | $466K | Buy |
2,309
+6
| +0.3% | +$1.25K | 0.16% | 38 |
|
|
2021
Q1 | $495K | Sell |
2,303
-2,057
| -47% | -$452K | 0.31% | 24 |
|
|
2020
Q4 | $1.03M | Sell |
4,360
-156
| -3% | -$35.8K | 3.87% | 7 |
|
|
2020
Q3 | $1.23M | Sell |
4,516
-273
| -6% | -$75.3K | 0.67% | 19 |
|
|
2020
Q2 | $1.39M | Sell |
4,789
-5,147
| -52% | -$1.4M | 0.82% | 11 |
|
|
2020
Q1 | $2.27M | Buy |
9,936
+4,789
| +93% | +$1.1M | 0.98% | 16 |
|
|
2019
Q4 | $1.13M | Buy |
5,147
+62
| +1% | +$12.5K | 0.4% | 23 |
|
|
2019
Q3 | $862K | Buy |
5,085
+99
| +2% | +$17.5K | 0.48% | 19 |
|
|
2019
Q2 | $914K | Buy |
4,986
+2,505
| +101% | +$438K | 0.36% | 16 |
|
|
2019
Q1 | $456K | Buy |
2,481
+236
| +11% | +$43.6K | 0.17% | 32 |
|
|
2018
Q4 | $372K | Buy |
+2,245
| New | +$389K | 0.45% | 25 |
|
|
2017
Q3 | – | Sell |
-2,697
| Closed | -$348K | – | 36 |
|
|
2017
Q2 | $348K | Sell |
2,697
-642
| -19% | -$77.3K | 0.46% | 12 |
|
|
2017
Q1 | $365K | Sell |
3,339
-1,660
| -33% | -$146K | 0.3% | 15 |
|
|
2016
Q4 | $368K | Sell |
4,999
-251
| -5% | -$20.4K | 0.19% | 31 |
|
|
2016
Q3 | $458K | Sell |
5,250
-1,981
| -27% | -$187K | 0.04% | 30 |
|
|
2016
Q2 | $622K | Buy |
7,231
+1,411
| +24% | +$122K | 0.12% | 30 |
|
|
2016
Q1 | $463K | Buy |
+5,820
| New | +$526K | 0.19% | 31 |
|
Other funds holding VRTX
VCM
VPM
JGP Global Gestao de Recursos's VRTX Position: Q1 2026 in Review
JGP Global Gestao de Recursos increased its Vertex Pharmaceuticals (VRTX) stake by 0.94% in Q1 2026, buying an estimated $2.33K and bringing the position to 537 shares worth $240K. The position accounts for 1.04% of the portfolio, ranked #18.
JGP Global Gestao de Recursos first reported a position in VRTX in Q1 2016 and has held it in 36 quarters since. The position peaked at $2.27M in Q1 2020. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- JGP Global Gestao de Recursos held 537 shares of Vertex Pharmaceuticals worth $240K as of Q1 2026.
- JGP Global Gestao de Recursos bought 5 Vertex Pharmaceuticals shares in Q1 2026, an estimated $2.33K.
- Vertex Pharmaceuticals made up 1.04% of JGP Global Gestao de Recursos's portfolio in Q1 2026, its #18 holding.
- JGP Global Gestao de Recursos first reported a position in Vertex Pharmaceuticals in Q1 2016 and has held it in 36 quarters since.
- JGP Global Gestao de Recursos's Vertex Pharmaceuticals position peaked at $2.27M in Q1 2020.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on JGP Global Gestao de Recursos's 13F filing for Q1 2026, filed 8 May 2026.